CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 228 enrolled
Drug / intervention
TRP-200 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04885296
NCT04885296N/ACompleted
CompareCT.gov

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

Johnson & Johnson Vision Care, Inc.·interventional·Posted May 13, 2021·Updated Sep 1, 2022

In Brief

A clinical study evaluating TRP-200 and JJVC Marketed Contact Lens for Visual Acuity. Completed, enrolled 228 participants across 12 sites.

Detailed Summary

This is a bilateral, 2-week dispensing, randomized, controlled, subject-masked, 2×2 crossover study to evaluate the clinical performance of prototype contact lenses with experimental UV/HEV-blocker.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 13, 2021
Enrollment StartMay 10, 2021
Primary CompletionAug 9, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.1 years ago

Interventions

TRP-200device

JJVC Investigational Contact Lens

JJVC Marketed Contact Lensdevice

ACUVUE Oasys 1-Day